Feasibility of transurethral resection of bladder lesion performed entirely by means of narrow-band imaging

Angelo Naselli, Carlo Introini, Franco Bertolotto, Bruno Spina, Paolo Puppo

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose: To assess the feasibility of transurethral resection (TUR) of bladder lesions performed entirely by means of a narrowband imaging (NBI) modality. Patients and Methods: Data from an ongoing prospective randomized trial (NCT01004211) were extracted. Quality outcomes of standard TUR and NBI TUR were compared. Complications were graded according to the Clavien-Dindo system. Results: To date, 33 and 29 subjects were randomized to standard and NBI TUR. No significant differences regarding age, sex, American Society of Anesthesiologists score, rate of multiple lesions, or lesions larger than 3? cm in the two groups were found, whereas rate of TUR for recurrent bladder cancer was greater in the NBI group. All procedures ended with complete clearance of the suspected or overt bladder tumor in the modality assigned. No death or major surgical or medical complications were registered. Overall grade I to II complications rate in the NBI and standard groups was, respectively, 8/29 (27%) and 11/33 (33%) (P? =? 0.831). Median surgery time was, respectively, 20 and 30 minutes in the NBI and standard group (P? =? 0.381). Median time to catheter removal was, respectively, 2 and 3 days in the NBI and standard groups (P? =? 0.288). Median time to discharge was 2 and 3 days (P? =? 0.173). No patient was readmitted after discharge. Muscle tissue was absent in the specimen of one patient who underwent standard TUR. Conclusion: NBI TUR appears to be feasible. The results of the ongoing randomized trial will show whether NBI TUR is able to reduce significantly the 1-year recurrence rate of bladder tumors.

Original languageEnglish
Pages (from-to)1131-1134
Number of pages4
JournalJournal of Endourology
Volume24
Issue number7
DOIs
Publication statusPublished - Jul 1 2010

Fingerprint

Narrow Band Imaging
Urinary Bladder
Urinary Bladder Neoplasms
Catheters

ASJC Scopus subject areas

  • Urology

Cite this

Feasibility of transurethral resection of bladder lesion performed entirely by means of narrow-band imaging. / Naselli, Angelo; Introini, Carlo; Bertolotto, Franco; Spina, Bruno; Puppo, Paolo.

In: Journal of Endourology, Vol. 24, No. 7, 01.07.2010, p. 1131-1134.

Research output: Contribution to journalArticle

Naselli, Angelo ; Introini, Carlo ; Bertolotto, Franco ; Spina, Bruno ; Puppo, Paolo. / Feasibility of transurethral resection of bladder lesion performed entirely by means of narrow-band imaging. In: Journal of Endourology. 2010 ; Vol. 24, No. 7. pp. 1131-1134.
@article{c7847581515748499f6cea222e303c15,
title = "Feasibility of transurethral resection of bladder lesion performed entirely by means of narrow-band imaging",
abstract = "Purpose: To assess the feasibility of transurethral resection (TUR) of bladder lesions performed entirely by means of a narrowband imaging (NBI) modality. Patients and Methods: Data from an ongoing prospective randomized trial (NCT01004211) were extracted. Quality outcomes of standard TUR and NBI TUR were compared. Complications were graded according to the Clavien-Dindo system. Results: To date, 33 and 29 subjects were randomized to standard and NBI TUR. No significant differences regarding age, sex, American Society of Anesthesiologists score, rate of multiple lesions, or lesions larger than 3? cm in the two groups were found, whereas rate of TUR for recurrent bladder cancer was greater in the NBI group. All procedures ended with complete clearance of the suspected or overt bladder tumor in the modality assigned. No death or major surgical or medical complications were registered. Overall grade I to II complications rate in the NBI and standard groups was, respectively, 8/29 (27{\%}) and 11/33 (33{\%}) (P? =? 0.831). Median surgery time was, respectively, 20 and 30 minutes in the NBI and standard group (P? =? 0.381). Median time to catheter removal was, respectively, 2 and 3 days in the NBI and standard groups (P? =? 0.288). Median time to discharge was 2 and 3 days (P? =? 0.173). No patient was readmitted after discharge. Muscle tissue was absent in the specimen of one patient who underwent standard TUR. Conclusion: NBI TUR appears to be feasible. The results of the ongoing randomized trial will show whether NBI TUR is able to reduce significantly the 1-year recurrence rate of bladder tumors.",
author = "Angelo Naselli and Carlo Introini and Franco Bertolotto and Bruno Spina and Paolo Puppo",
year = "2010",
month = "7",
day = "1",
doi = "10.1089/end.2010.0042",
language = "English",
volume = "24",
pages = "1131--1134",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "7",

}

TY - JOUR

T1 - Feasibility of transurethral resection of bladder lesion performed entirely by means of narrow-band imaging

AU - Naselli, Angelo

AU - Introini, Carlo

AU - Bertolotto, Franco

AU - Spina, Bruno

AU - Puppo, Paolo

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Purpose: To assess the feasibility of transurethral resection (TUR) of bladder lesions performed entirely by means of a narrowband imaging (NBI) modality. Patients and Methods: Data from an ongoing prospective randomized trial (NCT01004211) were extracted. Quality outcomes of standard TUR and NBI TUR were compared. Complications were graded according to the Clavien-Dindo system. Results: To date, 33 and 29 subjects were randomized to standard and NBI TUR. No significant differences regarding age, sex, American Society of Anesthesiologists score, rate of multiple lesions, or lesions larger than 3? cm in the two groups were found, whereas rate of TUR for recurrent bladder cancer was greater in the NBI group. All procedures ended with complete clearance of the suspected or overt bladder tumor in the modality assigned. No death or major surgical or medical complications were registered. Overall grade I to II complications rate in the NBI and standard groups was, respectively, 8/29 (27%) and 11/33 (33%) (P? =? 0.831). Median surgery time was, respectively, 20 and 30 minutes in the NBI and standard group (P? =? 0.381). Median time to catheter removal was, respectively, 2 and 3 days in the NBI and standard groups (P? =? 0.288). Median time to discharge was 2 and 3 days (P? =? 0.173). No patient was readmitted after discharge. Muscle tissue was absent in the specimen of one patient who underwent standard TUR. Conclusion: NBI TUR appears to be feasible. The results of the ongoing randomized trial will show whether NBI TUR is able to reduce significantly the 1-year recurrence rate of bladder tumors.

AB - Purpose: To assess the feasibility of transurethral resection (TUR) of bladder lesions performed entirely by means of a narrowband imaging (NBI) modality. Patients and Methods: Data from an ongoing prospective randomized trial (NCT01004211) were extracted. Quality outcomes of standard TUR and NBI TUR were compared. Complications were graded according to the Clavien-Dindo system. Results: To date, 33 and 29 subjects were randomized to standard and NBI TUR. No significant differences regarding age, sex, American Society of Anesthesiologists score, rate of multiple lesions, or lesions larger than 3? cm in the two groups were found, whereas rate of TUR for recurrent bladder cancer was greater in the NBI group. All procedures ended with complete clearance of the suspected or overt bladder tumor in the modality assigned. No death or major surgical or medical complications were registered. Overall grade I to II complications rate in the NBI and standard groups was, respectively, 8/29 (27%) and 11/33 (33%) (P? =? 0.831). Median surgery time was, respectively, 20 and 30 minutes in the NBI and standard group (P? =? 0.381). Median time to catheter removal was, respectively, 2 and 3 days in the NBI and standard groups (P? =? 0.288). Median time to discharge was 2 and 3 days (P? =? 0.173). No patient was readmitted after discharge. Muscle tissue was absent in the specimen of one patient who underwent standard TUR. Conclusion: NBI TUR appears to be feasible. The results of the ongoing randomized trial will show whether NBI TUR is able to reduce significantly the 1-year recurrence rate of bladder tumors.

UR - http://www.scopus.com/inward/record.url?scp=77954889368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954889368&partnerID=8YFLogxK

U2 - 10.1089/end.2010.0042

DO - 10.1089/end.2010.0042

M3 - Article

C2 - 20509796

AN - SCOPUS:77954889368

VL - 24

SP - 1131

EP - 1134

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 7

ER -